PetMed Express D/B/A 1-800-PetMeds Announces Its First Quarter Financial Results and Its $0.19 Per Share Quarterly Dividend

First Quarter Net Income Increased 15%
First Quarter New Order Sales Increased 10%

POMPANO BEACH, Fla., July 25, 2016 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ:PETS) today announced its financial results for the quarter ended June 30, 2016. Net income was $6.6 million, or $0.32 diluted per share, for the quarter ended June 30, 2016, compared to net income of $5.8 million, or $0.29 diluted per share, for the quarter ended June 30, 2015, a 15% increase to net income. Net sales for the quarter ended June 30, 2016 were $72.5 million, compared to $71.6 million for the quarter ended June 30, 2015, an increase of 1.2%. New order sales increased 10%, to $13.3 million for the quarter ended June 30, 2016, compared to $12.1 million for the same quarter in the prior year. The Company’s online sales for the quarter ended June 30, 2016 were approximately 82% of all sales compared to 81% for the same quarter the prior year, an increase of 2.9%.

Menderes Akdag, CEO and President, commented: “During the June quarter we saw increases in our new order sales, acquiring approximately 158,000 new customers, compared to 148,000 new customers acquired in the same quarter the prior year. We were further encouraged by our continued advertising efficiency in the quarter, as our new customer acquisition costs were reduced to $37 for the quarter ended June 30, 2016 compared to $53 for the same quarter the prior year. We were able to decrease our operating expenses to improve our bottom line results for the quarter ended June 30, 2016. Our operating expenses decreased by about 274 basis points for the quarter compared to the same quarter last year, which can be attributed to a reduction in advertising spending. For the remainder of Fiscal 2017 we will be preparing to move into our new corporate headquarters and distribution facility, which is expected to occur in our third fiscal quarter.”

The Board of Directors declared a quarterly dividend of $0.19 per share on the Company’s common stock. The dividend will be payable on August 19, 2016, to shareholders of record at the close of business on August 8, 2016. The Company intends to continue to pay regular quarterly dividends; however, the declaration and payment of future dividends is discretionary and will be subject to a determination by the Board of Directors each quarter following its review of the Company’s financial performance.

This morning at 8:30 A.M. Eastern Time, Mr. Akdag will host a conference call to review the quarter’s financial results. To access the call, which is open to the public, please dial (888) 455-1758 (toll free) or (203) 827-7025. Callers will be required to supply PETMEDS as the passcode. For those unable to participate in the live event, the call will be available for replay from 10:00 A.M. on July 25, 2016 until August 8, 2016 at 11:59 P.M. To access the replay, call (866) 425-0192 (toll free) or (203) 369-0875, and enter passcode 5500.

Founded in 1996, PetMed Express is America’s Largest Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs and cats at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at

This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2016. The Company’s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K.

For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 954-979-5995.

(In thousands)
June 30, March 31,
2016 2016
ASSETS (Unaudited)
Current assets:
Cash and cash equivalents $44,307 $37,639
Accounts receivable, less allowance for doubtful
accounts of $16 and $13, respectively 2,075 1,724
Inventories - finished goods 27,026 25,586
Prepaid expenses and other current assets 3,865 2,435
Prepaid income taxes - 243
Total current assets 77,273 67,627
Noncurrent assets:
Property and equipment, net 20,766 20,929
Intangible assets 860 860
Deferred tax assets 907 863
Total noncurrent assets 22,533 22,652
Total assets $99,806 $90,279
Current liabilities:
Accounts payable $7,281 $5,004
Accrued expenses and other current liabilities 2,503 2,080
Income taxes payable 3,655 -
Total liabilities 13,439 7,084
Commitments and contingencies
Shareholders' equity:
Preferred stock, $.001 par value, 5,000 shares authorized;
3 convertible shares issued and outstanding with a
liquidation preference of $4 per share 9 9
Common stock, $.001 par value, 40,000 shares authorized;
20,447 and 20,447 shares issued and outstanding, respectively 20 20
Additional paid-in capital 5,334 4,871
Retained earnings 81,004 78,295
Total shareholders' equity 86,367 83,195
Total liabilities and shareholders' equity $99,806 $90,279

(In thousands, except for per share amounts) (Unaudited)
Three Months Ended
June 30,
2016 2015
Sales $72,487 $ 71,634
Cost of sales 50,035 48,668
Gross profit 22,452 22,966
Operating expenses:
General and administrative 6,098 5,799
Advertising 5,760 7,885
Depreciation 194 191
Total operating expenses 12,052 13,875
Income from operations 10,400 9,091
Other income:
Interest income, net 28 50
Other, net 53 (4)
Total other income 81 46
Income before provision for income taxes 10,481 9,137
Provision for income taxes 3,887 3,380
Net income $6,594 $ 5,757
Net change in unrealized gain (loss) on short
term investments - (35)
Comprehensive income $6,594 $ 5,722
Net income per common share:
Basic $0.33 $ 0.29
Diluted $0.32 $ 0.29
Weighted average number of common shares outstanding:
Basic 20,181 20,074
Diluted 20,333 20,198
Cash dividends declared per common share $0.19 $ 0.18

(In thousands) (Unaudited)
Three Months Ended
June 30,
2016 2015
Cash flows from operating activities:
Net income $ 6,594 $ 5,757
Adjustments to reconcile net income to net cash
provided by operating activities:
Depreciation 194 191
Share based compensation 463 371
Deferred income taxes (44) (148)
Bad debt expense 233 168
(Increase) decrease in operating assets
and increase (decrease) in liabilities:
Accounts receivable (584) (1,326)
Inventories - finished goods (1,440) (2,152)
Prepaid income taxes 243 -
Prepaid expenses and other current assets 1,143 (161)
Accounts payable 2,277 4,827
Income taxes payable 3,655 3,302
Accrued expenses and other current liabilities 372 (18)
Net cash provided by operating activities 13,106 10,811
Cash flows from investing activities:
Net change in investments - (16)
Purchases of property and equipment (2,604) (110)
Net cash used in investing activities (2,604) (126)
Cash flows from financing activities:
Dividends paid (3,834) (3,613)
Net cash used in financing activities (3,834) (3,613)
Net increase in cash and cash equivalents 6,668 7,072
Cash and cash equivalents, at beginning of period 37,639 35,613
Cash and cash equivalents, at end of period $ 44,307 $ 42,685
Supplemental disclosure of cash flow information:
Cash paid for income taxes $ 55 $ 226
Property and equipment in current assets $ 2,573 $ -
Dividends payable in accrued expenses $ 194 $ 245

Source:PetMed Express, Inc.